We Develop Polyclonal Antibodies to Assist the Pharmaceutical and Food Producers to Achieve an Effective Product Based On a Nature-Friendly Primary Ingredient

Edit Content

Start
2009

Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.

Start
2009

Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.

Edit Content

First In vitro Test
2010

In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.

First In vitro Test
2010

In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.

Edit Content

First In vivo Test
2011

In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.

First In vivo Test
2011

In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.

Edit Content

Product Development
2012

The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.

Product Development
2012

The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.

Edit Content

Technological Development
2014

Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs

Technological Development
2014

Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs

Edit Content

Royan Biotechnology Award
2016-2017

By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.

Royan Biotechnology Award
2016-2017

By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.

Edit Content

Technological Development
2018

Success in a highly efficient process of extraction and processing while preserving the structure and function of antibodies.

Technological Development
2018

Success in a highly efficient process of extraction and
processing while preserving the structure and function of
antibodies.

Edit Content

Commercial Development
2020

Royan Biotechnologist Immuno company officially registered
product development and sales units.

Commercial Development
2020

Royan Biotechnologist Immuno company officially registered
product development and sales units.

Edit Content

Royan Innovative Technologies Center
2021

Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)

Royan Innovative Technologies Center
2021

Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)

Edit Content

Drug Design Development
2022

Research and development in antibody therapy of
Inflammatory bowel disease

Drug Design Development
2022

Research and development in antibody therapy of
Inflammatory bowel disease

Edit Content

Start
2009

Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.

Start
2009

Our founder came close to the idea of producing
biotechnology products at Royan Biotechnology
Research Institute.

Edit Content

First In vitro Test
2010

In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.

First In vitro Test
2010

In the first laboratory experiment with polyclonal
antibodies, they succeeded in inhibiting the growth
of E.coli bacteria.

Edit Content

First In vivo Test
2011

In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.

First In vivo Test
2011

In the first invivo test, they succeeded in producing an
immunotherapy drug with polyclonal antibody to treat
diarrhea in calves.

Edit Content

Product Development
2012

The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.

Product Development
2012

The development of knowledge-based drug and
supplements is associated with the establishment of
technology in the field of biotechnology.

Edit Content

Technological Development
2014

Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs

Technological Development
2014

Obtaining a research grant for the development of technical
knowledge and the production of immunotherapy drugs

Edit Content

Royan Biotechnology Award
2016-2017

By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.

Royan Biotechnology Award
2016-2017

By designing pharmaceutical products and supplements, it won
the award for the best technological project of the country in
2016 and the best designed products of the University
Educational, Cultural and Research Center (ACECR) in 2017.

Edit Content

Technological Development
2018

Success in a highly efficient process of extraction and processing while preserving the structure and function of antibodies.

Technological Development
2018

Success in a highly efficient process of extraction and
processing while preserving the structure and function of
antibodies.

Edit Content

Commercial Development
2020

Royan Biotechnologist Immuno company officially registered
product development and sales units.

Commercial Development
2020

Royan Biotechnologist Immuno company officially registered
product development and sales units.

Edit Content

Royan Innovative Technologies Center
2021

Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)

Royan Innovative Technologies Center
2021

Establishment at the location of Royan Center technology
companies in Royan Innovative Technologies Acceleration
and Commercialization Center (RITAC)

Edit Content

Drug Design Development
2022

Research and development in antibody therapy of
Inflammatory bowel disease

Drug Design Development
2022

Research and development in antibody therapy of
Inflammatory bowel disease

Problam

Solution

Product

our SOLUTIONS

Mechanism of Antibody Therapy

Generally the action of orally administered IgG is intended to be achieved within a specific localized site along the alimentary tract

Several mechanisms of action is proposed in host protection:

  1. Inhibition the microbial adhesion to the surface of cells.
  2. Suppression of viral colonization by preventing cell-to-cell spread.
  3. Bacterial agglutination with microbial immobilization and death or ease of being flushed down in gut.
  4. Inhibition of enzyme activity.
  5. Neutralization of toxin activity. 

1 .We know how to design and use Antigen

3 .We know how to extract pure antibody in large scale

Global Problem Noncommunicable diseases (NCDs) Infectious disease and pandemics Antibiotic-resistant microbes

2 .We know how to make large scale Antibody

4 .We introduce our antibodies to makes your drug formula

Global Problem

Noncommunicable diseases (NCDs) Infectious disease and pandemics Antibiotic-resistant microbes

Mechanism of Antibody Therapy

Generally the action of orally administered IgG is intended to be achieved within a specific localized site along the alimentary tract

Several mechanisms of action is proposed in host protection:

  1. Inhibition the microbial adhesion to the surface of cells.
  2. Suppression of viral colonization by preventing cell-to-cell spread.
  3. Bacterial agglutination with microbial immobilization and death or ease of being flushed down in gut.
  4. Inhibition of enzyme activity.
  5. Neutralization of toxin activity. 

 

Therapeutic Antibodies Have Become One of The Fastest Growing Classes of Drugs in Recent Years and Are Approved For the Treatment of a Wide Range of Disease

Vision

Inspiring sustainable health using biotechnologies

MISSION

Polyclonal antibody production using nature friendly methods as effective raw materials for the production of innovative food, pharmaceutical and cosmetic products.

our TEAM​

Mohammad Hossein Nasr-Esfahani

Senior Scientist- Co-Founder

Sirous Ghaedi

CEO

Iqan Imamverdi

Consultant to CEO

Maryam Dianati

Scientist

Mehnaz Dianati

Expert R&D

Mehrangiz Piri

Scientist

Nazanin Jamshidi

Expert R&D

Mehr-sadat Tabaeian

QC & Laboratory executive officer

Bahar Rafiezadeh

Expert R&D

Nasim Hatamzadeh

Expert R&D

bahar rafiezadeh

Expert R&D

Nasim Hatamzadeh

Expert R&D

Mehr-alsadat Tabaeian

QC & Laboratory executive officer

Mehrangiz Piri

Scientist

Maryam Dianati

Scientist

Nazanin Jamshidi

Expert R&D

Mehnaz Dianati

Expert R&D

our PARTNERS